Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Aphios receives phase I SBIR grant from NIDA to develop dronabinol for marijuana addiction

Oct. 29, 2008

PharmAthene initiates phase I trial of nerve agent bioscavenger Protexia

Oct. 29, 2008

Evotec reports results from phase I safety study of EVT-302

Oct. 29, 2008

Anti-flunitrazepam monoclonal antibody prevents sedative and cognitive effects of flunitrazepam

Oct. 23, 2008

Avigen initiates exploratory study of AV-411 in opioid withdrawal

Oct. 16, 2008

Cellerant Therapeutics receives contract for acute radiation syndrome treatment

Sep. 29, 2008

Evotec initiates phase II proof-of-concept EVT-302 trial in smoking cessation

Sep. 16, 2008

Pilot study finds effect of tiagabine in alcoholism

Sep. 2, 2008

Cortex reports positive results from RD-02 phase IIa clinical trial of Ampakine in RD

Aug. 11, 2008

University of Texas Southwestern Medical Center initiates clinical trial of DOR's RiVax

Aug. 8, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...